MAUDE Adverse Event Report: MEDIVANCE, INC. ¿ 1725056 ARCTIC SUN TEMPERATURE MANAGEMENT SYSTEM, ARCTICGEL PADS; ARCTIC GEL PAD

Catalog Number 317-07-02-BARD

Device Problems Inaccurate Flow Rate (1249); Appropriate Term/Code Not Available (3191)

Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)

Event Date 09/10/2020

Event Type  malfunction  

Manufacturer Narrative

The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.

Event Description

It was reported that the patient on the arctic sun device was above target temperature of 37.5c with a rectal temperature of 38c (temperature 1), esophageal temperature of 37.7c (on monitor), flow rate was marginal of 1.5 lpm and patient was 55kg.Gel pads changed yesterday and the patient has been on and off the bear hugger with restlessness and pulling off blankets.Patient was not shivering and no other alarms were observed.Mss advised that the device looked good and advised using the esophageal as primary temperature (temperature 1).Per follow-up with nurse lee on 16sep2020, the first set of pads was exchanged due to 5 day age.There was no issue with the first pads.They did not troubleshoot the flow rate on the second pads.Patient reached target temperature and completed therapy.

Manufacturer Narrative

The reported event was inconclusive as no sample returned for evaluation.A potential root cause for this failure mode could be due to belt temperatures too low after nip roller and heated section.It was unknown whether the device had met specifications.The product used for the treatment but it was unknown whether the product had caused the reported failure.The device was not returned for evaluation.The lot number was unknown therefore the device history record could not be reviewed.The instructions for use were found adequate and state the following: "indications for use 1) the arctic sun temperature management system is intended for monitoring and controlling patient temperature in adult and pediatric patients of all ages.Contraindications 1) there are no known contraindications for the use of a thermoregulatory system.2) do not place arcticgel pads on skin that has signs of ulcerations, burns, hives or rash.3) while there are no known allergies to hydrogel materials, caution should be exercised with any patient with a history of skin allergies or sensitivities.Warning 1) do not place arcticgel pads over transdermal medication patches as warming can increase drug delivery, resulting in possible harm to the patient.Cautions 1) federal law restricts this device to sale by or on the order of a physician.2) this product is to be used by or under the supervision of trained, qualified medical personnel.3) the clinician is responsible for determining the appropriateness of use of this device and the user settable parameters, including water temperature, for each patient.4) due to underlying medical or physiological conditions, some patients are more susceptible to skin damage from pressure and heat or cold.Patients at risk include those with poor tissue perfusion or poor skin integrity due to edema, diabetes, peripheral vascular disease, poor nutritional status or steroid or high dose vasopressor therapy.If accessible, examine the patient¿s skin under the arcticgel pads often especially those patients at higher risk of skin injury.5) skin injury may occur as a cumulative result of pressure, time and temperature.Possible skin injuries include bruising, tearing, skin ulcerations, blistering, and necrosis.Do not place bean bags or other firm positioning devices under the arcticgel pads.Do not place any positioning devices under the pad manifolds or patient lines.6) do not allow urine, antibacterial solutions or other agents to pool underneath the arcticgel pads.Urine and antibacterial agents can absorb into the pad hydrogel and cause chemical injury and loss of pad adhesion.Replace pads immediately if these fluids come into contact with the hydrogel.7) do not place arcticgel pads directly over an electrosurgical grounding pad.The combination of heat sources may result in skin burns.8) carefully remove arcticgel pads from the patient¿s skin at the completion of use.Aggressive removal or removal of cold pads from the patient¿s skin may result in skin tears.9) the arcticgel pads are non-sterile for single patient use only.Do not place pads in the sterile field.If used in a sterile environment, pads should be placed according to the physician¿s directions, either prior to the sterile preparation or sterile draping.10) do not reprocess or sterilize.11) use pads immediately after opening.Do not store pads in opened pouch.12) do not allow circulating water to contaminate the sterile field when lines are disconnected.13) the arcticgel pads should not be punctured with sharp objects.Punctures will result in air entering the fluid pathway and may reduce performance.14) if warranted, use pressure relieving or pressure reducing devices under the patient to protect from skin injury.15) the arcticgel pads are only for use with an arctic sun temperature management system.16) the water content of the hydrogel affects the pad¿s adhesion to the skin and conductivity, and therefore, the efficiency of controlling patient temperature.Periodically check that pads remain moist and adherent.Replace pads when the hydrogel no longer uniformly adheres to the skin.Replacing pads at least every 5 days is recommended.17) if needed, place defibrillation pads between the arcticgel pads and the patient¿s skin.18) discard used arcticgel pads in accordance with hospital procedures for medical waste.Directions for use: 1.Arcticgel pads are only for use with an arctic sun temperature management system control module.See operators manual for detailed instructions on system use.2.Select the proper number, size and style pad for the patient size and clinical indication.However, the rate of temperature change and potentially the final achievable temperature is affected by pad surface area, patient size, pad placement and water temperature range.Best system performance will be achieved by using the entire pad set.If the entire set of pads is not used, the minimum flow rate may not be achieved.3.For patient comfort, the pads may be pre warmed using water temperature control mode (manual) prior to application.4.Place the pads on healthy, clean skin only.Remove any creams or lotions from patient¿s skin before pad application.Remove the release liner from each pad and apply to the appropriate area.The pads may be overlapped or folded adhesive-to-adhesive to achieve proper placement.The pads may be removed and reapplied if necessary.The pad surface must be contacting the skin for optimal energy transfer efficiency.Place pads to allow for full respiratory excursion.5.Attach the pad¿s line connectors to the patient line manifolds.Begin circulating water through the pads using either patient temperature control mode (automatic) or water temperature control mode (manual).If the pads fail to prime or a significant continuous air leak is observed in the pad return line, check connections, then if needed replace the leaking pad.6.Once the pads are primed, assure the flow rate displayed on the control panel is greater than 1.7 liters per minute, which is the minimum flow rate for a full pad kit.7.When finished, empty water from pads.Cold temperature increases the adhesiveness of the hydrogel.For ease of removal, leave pads on the patient for approximately 15 minutes to allow the hydrogel to warm.Slowly remove pads from the patient and discard." the device was not returned.

Event Description

It was reported that the patient on the arctic sun device was above the target temperature of 37.5 c with a rectal temperature of 38 c (temperature 1), esophageal temperature of 37.7 c (on monitor) the flow rate was marginal of 1.5 lpm and the patient weight with 55 kgs.The gel pads were changed and the patient was on and off the bair hugger with restlessness and pulling off the blankets.The patient was not shivering and no other alarms were observed.Ms and s advised that the device looks good and advised using the esophageal as primary temperature (temperature 1) per follow up with nurse on 16sep2020 the first set of pads were exchanged due to 5 day age.There was no issue with the first pad.They did not troubleshoot the flow rate on the second pads.The patient reached the target temperature and completed the therapy.

• Brand Name: ARCTIC SUN TEMPERATURE MANAGEMENT SYSTEM, ARCTICGEL PADS
• Type of Device: ARCTIC GEL PAD
• Manufacturer (Section D): MEDIVANCE, INC. ¿ 1725056; 321 s taylor ave; suite 200; louisville 80027
• MDR Report Key: 10650162
• MDR Text Key: 211460575
• Report Number: 1018233-2020-20006
• Device Sequence Number: 1
• Product Code: DWJ
• Combination Product (y/n): N
• PMA/PMN Number: K142702
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: health professional,other,use
• Type of Report: Initial,Followup
• Report Date: 03/04/2021

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Date FDA Received: 10/08/2020
• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Device Operator: Health Professional
• Device Catalogue Number: 317-07-02-BARD
• Was Device Available for Evaluation?: No
• Date Manufacturer Received: 03/04/2021
• Is This a Reprocessed and Reused Single-Use Device?: No
• Patient Sequence Number: 1
• Patient Outcome(s): Other
• Patient Weight: 55